Main| Contact Us| BP Claims| Site Map
Ask Attorney Logo Call Ask Attorney
Home | Accidents | Diseases | Drugs & Devices | Medical Malpractice | Products Liability | Other | Pollutants |
   
 
Drugs & Devices > Gadolinium



WHAT IS GADOLINIUM?

Gadolinium is a metal ion used with patients undergoing magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA).  Gadolinium-based agents are approved by the FDA as contrast agents to provide a clearer picture of organs and tissues.

GADOLINIUM LAWSUIT


If you or a loved one has developed skin problems or limb immobility after receiving an MRI or MRA you should seek immediate medical attention.

If you or a loved one has developed Nephrogenic Systemic Fibrosis after receiving a gadolinium contrast agent during an MRI or MRA, you may have the legal right to seek compensation for your losses and suffering, including medical expenses, disability, death, pain and suffering, and more. To receive a free consultation, please contact our qualified and experienced Gadolinium lawyers who are dedicated to helping you and your family receive the compensation you deserve.

GADOLINIUM – INJECTIONS

An MRI contrast agent, gadolinium, injection can impair kidney function and lead to a potentially fatal disorder. This disorder, Nephrogenic Systemic Fibrosis, results in the formation of a thick, hardening of the skin on the arms and legs, and could involve scarring of internal organs. This disease is also referred to as Nephrogenic Fibrosing Dermopathy(NFD).

Symptoms of NSF/NSD may appear within two days or even as long as 18 months after exposure to the dye. The dosage associated with NSF/NSD can also vary.  Some patients developed the disease after receiving only one dose of the contrast agent.

FDA ORDERS BLACK BOX WARNING

A black box warning is the most serious warning the FDA can request be added to a drug, short of calling for the drug to be pulled off the market. The FDA requested the addition of a Gadolinium black box warning.

May 23, 2007 - The FDA announced today that it is asking manufacturers of gadolinium-based contrast agents to include a black box warning alerting patients to the risk of a potentially fatal disease.
The FDA stated that patients with kidney disease or chronic liver disease are at risk for developing nephrogenic systemic fibrosis (NSF), a disease characterized by a thickening of the skin and connective tissues that inhibit their ability to move.

On May 29, 2007 -  the Danish equivalent of the United States food and drug administration (FDA) reported a link in 25 patients with Gadolinium based contrast agents and Nephrogenic Systemic Fibrosis.

The Gadolinium-Based MRI Contrast Agents

The following gadolinium-based agents are implicated by the warning:

Magnevist (gadopentetate dimeglumine)

Omniscan (gadodiamide)

OptiMARK (gadoversetamide)

MultiHance (gadobenate dimeglumine)

ProHance (gadoteridol)

The FDA has been aware of problems with gadolinium since at least June 2006, when the agency warned healthcare professionals about the risk of nephrogenic systemic fibrosis (NSF). A subsequent warning was issued in December 2006.

Free initial consultation.  No fees unless we recover compensation for you.  Finding the right personal injury lawyer should not cost you any money.  Contact us today at 1-800-780-2686.

Breaking News

Gadolinium litigation involves 391 cases
391 lawsuits have been filed in state and federal court by individuals who claim that they developed a rare condition called Nephrogenic Systemic Fibrosis (NSF) after an enhanced MRI, court documents say... Read More
Woman Wins Gadolinium Lawsuit
A Tennessee woman suffering from Nephrogenic Systemic Fibrosis (NSF) has won a lawsuit with her insurance company. A judge has ordered TennCare to compensate for a treatment that could save Jeanie Deason’s life. The suit was filed two years back... Read More
Gadolinium Usage in MRI raises concerns

An incurable disease caused by a simple Magnetic Resonance Imaging (MRI) is raising concerns among several people....

Read More

Free Case Review
 

Gadolinium
  Abacavir |   ACE Inhibitors |   Advil |   Ambien |   Avandia |   Botox |   Celexa |   Chantix |   Cymbalta |   Cytotec |   Desmopressin |   Diabetes and Seroquel |   Dilantin |   Duragesic Patch |   Fentanyl |   Erythropoiesis-Stimulating Agents (ESAs) |   Fleet Enema |   Fosamax |   Gadolinium |   Gardasil |   Heart Attack and Avandia |   Heparin |   Hydroxycut |   Kugel Mesh Patch |   Levaquin |   Levitra |   Meridia |   Motrin |   Neurontin |   NuvaRing |   Ortho Evra Patch |   Oxycontin |   Paxil |   Paxil & Breast Cancer |   Prempro |   Prozac |   Raptiva |   Reglan |   ReNu Contact Solution |   Ritalin |   Renu MultiPlus Solution |   Serevent |   Seroquel |   Shoulder Surgery and Pain Pump |   Singulair |   Tequin |   Tiazac |   Trasylol |   Viagra |   Vytorin |   Wellbutrin |   Xenadrine RFA-1 |   Xigris |   Xolair |   Yaz |   Zelnorm |   Zevalin |   Zicam |   Zithromax |   Zoloft |   Zometa |   Zyprexa |
AskAttorney.org Call Now (800) 780-2686

Home| Accidents| Diseases| Drugs & Devices| Medical Malpractice| Products Liability| Other| Pollutants| Conatct Us | Site Map